Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:starting:physician:reluctant [04.26.2019] – [Specific research] sallieqhome:starting:physician:reluctant [04.29.2019] – [Read more] sallieq
Line 176: Line 176:
 [[home:protocol:olmesartan:#other_benefits_of_olmesartan_in_patients_-_recent_studies|other benefits]] [[home:protocol:olmesartan:#other_benefits_of_olmesartan_in_patients_-_recent_studies|other benefits]]
  
-OLM refs to print;  for patient with doctor not a member of MPSS  +OLMesartan references to print out;  for patient with doctor not a member of MPSS  
-including information about dose relating to body weight, and dose timing+include information about dose relating to body weight, and dose timing
  
  
Line 294: Line 294:
 {{section>:home:protocol:olmesartan#recent_studies_of_olmesartan_in_patients}} {{section>:home:protocol:olmesartan#recent_studies_of_olmesartan_in_patients}}
  
-{{tag>Starting_the_Marshall_Protocol letters}}+{{tag>Starting_the_Marshall_Protocol letters resources_for_physicians}}
  
 ===== Notes and comments ===== ===== Notes and comments =====
home/starting/physician/reluctant.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.